0 results for 'Cardinal Health Systems Inc'
J&J Acquires Cordis Unit for $2B
Medical device and pharmaceutical company Johnson & Johnson, based in New Brunswick, said on May 28 that it will acquire Cardinal Health's Cordis medical device unit for $2 billion.J&J Acquires Cordis Unit for $2B
Medical device and pharmaceutical company Johnson & Johnson, based in New Brunswick, said on May 28 that it will acquire Cardinal Health's Cordis medical device unit for $2 billion.
Lifetime Achievement Award Winners
The following attorneys were selected for Lifetime Achievement Awards.
Lifetime Achievement Award Winners
The following attorneys were selected for Lifetime Achievement Awards.
Law Journal Press | Digital Book
Health Care Benefits Law
Authors: Jeffrey D. Mamorsky
View this Book
View more book results for the query "Cardinal Health Systems Inc"
J&J Sells Cordis for About $2B
Manufacturing conglomerate Johnson & Johnson in New Brunswick, New Jersey, announced on March 2 that its subsidiary, Freemont, California-based medical device maker Cordis, has been sold to health-care company Cardinal Health, of Dublin, Ohio, for $1.944 billion in cash.J&J Sells Cordis for About $2B
Manufacturing conglomerate Johnson & Johnson in New Brunswick, New Jersey, announced on March 2 that its subsidiary, Freemont, California-based medical device maker Cordis, has been sold to health-care company Cardinal Health, of Dublin, Ohio, for $1.944 billion in cash.
Deal Watch: Three Am Law Firms Lead on AbbVie's $21 Billion Pharma Buy
Big Pharma tops our latest roundup of deals worth $1 billion or more, with AbbVie Inc. agreeing to purchase cancer-drug maker Pharmacyclics Inc. for $21 billion. Skadden, Arps, Slate, Meagher & Flom advised on the most number of billion-dollar deals this week, with four, while Wachtell, Lipton, Rosen & Katz led the way by transaction value.
Deal Watch: Three Am Law Firms Lead on AbbVie's $21 Billion Pharma Buy
Big Pharma tops our latest roundup of deals worth $1 billion or more, with AbbVie Inc. agreeing to purchase cancer-drug maker Pharmacyclics Inc. for $21 billion. Skadden, Arps, Slate, Meagher & Flom advised on the most number of billion-dollar deals this week, with four, while Wachtell, Lipton, Rosen & Katz led the way by transaction value.Trending Stories
- 1Joshua Wright's $108M Defamation Case Against Former Students to Proceed to Trial
- 2Future of Litigation: Keeping Pace with the Rapid Rate of Change
- 3In Wake of Sexual Misconduct Allegations Against Ex-Law Professor, GMU Bans Intimate Relationships With Students
- 4Joshua Wright Sues GMU for Alleged Title IX Violations, but Has $108M Defamation Suit Against Accusers Tossed
- 5How Attorney Titles in Big Law Can Mean Everything, and Nothing, All at Once
More from ALM
- Morgan & Morgan Class Action Attorneys Detail Pathway to Success Within Cybersecurity and Data Privacy Practice 1 minute read
- Holwell Shuster & Goldberg Partners Leverage 'Hostile' Witnesses to Secure $101 Million Verdict Against Walmart 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
Resources
Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House
Brought to you by LexisNexis®
Download Now
Insights and Strategies for Effective Succession Planning in AM Law 100 Firms
Brought to you by Gallagher
Download Now
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now